The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Viatris (VTRS) has quietly climbed about 14% over the past month and roughly 21% in the past 3 months, even though the share price is still slightly negative year to date. See our latest analysis for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other ...

Viatris Inc. (NASDAQ:VTRS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 9, Barclays ...

Viatris is a pharmaceutical company with a diverse portfolio of branded drugs, generics, and biosimilars. It reported strong Q2 2024 performance with operational revenue growth, adjusted EBITDA, and ...

We recently compiled a list of 10 Best Stocks Under $15 To Buy Now. In this article, we will look at where Viatris Inc. (NASDAQ:VTRS) ranks among the best stocks under $15. While September is usually ...

Investors in Viatris Inc (Symbol: VTRS) saw new options become available this week, for the July 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, ...